Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Los Angeles-based firm Sidmap will collaborate with the Johns Hopkins School of Medicine in lung cancer metabolomics research using funding JHU was granted from the National Cancer Institute, the company said today.

The $340,000 grant will be used to test if a gain in function of a certain gene transcription factor called Nrf2 promotes tumorigenesis in the presence of a cancer-causing signal.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.

Oct
06
Sponsored by
10x Genomics

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease characterized by irreversible scarring of the distal lung, leading to respiratory failure.